Bromeact is a dietary supplement in capsules with three ingredients of plant origin, bromelain from pineapple, Boswellia serrata acid from the Boswellia plant and coumarin.
None of these three substances has an approved health claim in the European Union. Below is a description of each and where it comes from, without a claim of action or effect. It is intended for adults interested in enzymatic and botanical formulations as part of their daily routine.
Bromelain is not a vitamin or herb, it is a mixture of proteolytic enzymes, that is, enzymes that break down proteins. It is isolated from the fruit and especially from the stem of the pineapple (Ananas comosus). It is one of the most studied plant enzymes internationally and its activity is usually expressed in enzyme units, not just in milligrams. There is no approved health claim for bromelain.
Boswellic acid is a pentacyclic triterpenic acid found in the resin of Boswellia trees, also known as frankincense. This resin has been used for centuries in the Indian tradition of Ayurveda and is now standardized based on its content of boswellic acids.**
Coumarin is a natural aromatic compound of the benzopyranone category, found in plants such as wild clover, cassia cinnamon and tonka bean. It is responsible for the characteristic smell of freshly cut grass. It should not be confused with coumarin anticoagulant drugs, which are synthetic derivatives with completely different use.**
For adults who want a formulation with plant enzymes and botanical extracts in a standardized capsule form. For those who prefer to take bromelain in supplement form rather than relying on the amount of fresh pineapple.
Should not be taken by people with hypersensitivity to bromelain or Boswellia, or with allergy to pineapple, celery, carrot or grass pollen allergy. Not intended for children.
Follow the dosage on the package and do not exceed the recommended daily dose.
Since it is a proteolytic enzyme, the time of intake in relation to meals is specified on the product label. Follow it or ask your pharmacist.
Not without medical advice. Inform your doctor if you are taking anticoagulants or antiplatelet drugs such as warfarin, acenocoumarol, aspirin or clopidogrel.
Inform your doctor and stop taking it before any scheduled surgical or dental procedure, following your doctor's instructions.
Then this product is not for you. The same applies to allergy to celery, carrot and grass pollen.
It contains 30 capsules. With one capsule per day it covers one month, always according to the dosage indicated on the label.
No. It is a dietary supplement with EFSA Notification Number 28343 / 8-4-2013. The Notification Number with EFSA does not imply a marketing authorization from EFSA.
Bromeact is a dietary supplement and is not intended to prevent, treat or cure human disease. It does not replace a balanced diet and a healthy lifestyle.
** Information on the plant ingredients. The related health claims for botanicals are under evaluation by EFSA.
Active ingredients: bromelain from pineapple, Boswellia serrata acid (Boswellia), coumarin.
For the exact contents and enzyme activity of bromelain, consult the packaging label.
Take according to the instructions on the package.
Should not be taken in case of hypersensitivity to bromelain or Boswellia, or with allergy to pineapple, celery, carrot or grass pollen.
Interactions: if you are taking anticoagulants or antiplatelet drugs, such as warfarin, acenocoumarol, aspirin or clopidogrel, consult your doctor before use. Stop taking it before any scheduled surgical or dental procedure, following your doctor's instructions.
Do not exceed the recommended daily dose. Dietary supplements should not be used as a substitute for a balanced diet. The product is not intended to prevent, treat or cure human disease. Keep the product in a cool and dry place, out of reach of children. Pregnancy, breastfeeding or medication: consult your doctor or pharmacist before use.
EFSA Notification Number: 28343 / 8-4-2013 (The Notification Number with EFSA does not imply a marketing authorization from EFSA)
